ABELLARD LOUIS-JEUNE: Open Payments
NPI 1285227579 · JAMAICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 21 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $182 · 2025 $581
Food & beverage: $581
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $121 |
| ABBVIE INC. | 5 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $80 |
| GlaxoSmithKline, LLC. | 3 | $78 |
| Xeris Pharmaceuticals, Inc. | 2 | $50 |
| SHIELD THERAPEUTICS INC | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| Renalytix AI, Inc. | 1 | $25 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $23 |
| Amgen Inc. | 1 | $18 |
Products named: Ozempic, Kerendia, QULIPTA, SHINGRIX, GVOKE HYPOPEN, ACCRUFER, UBRELVY, FARXIGA.
Industry payments across NY — which companies pay providers there.
